These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6896955)

  • 21. Brain-fluid barriers: relevance for theoretical controversies regarding vasopressin and oxytocin memory research.
    McEwen BB
    Adv Pharmacol; 2004; 50():531-92, 655-708. PubMed ID: 15350270
    [No Abstract]   [Full Text] [Related]  

  • 22. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
    Manning M; Stoev S; Chini B; Durroux T; Mouillac B; Guillon G
    Prog Brain Res; 2008; 170():473-512. PubMed ID: 18655903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Action of vasopressin analog on neuronal excitability in Helix lucorum.
    Kudryashova IV; Logunov DB
    Neurosci Behav Physiol; 1987; 17(5):407-14. PubMed ID: 3431686
    [No Abstract]   [Full Text] [Related]  

  • 24. Arginine vasopressin antagonism of oxytocin-stimulated PGE2 release from rabbit amnion cells and the activities of thioanalogs of oxytocin and arginine vasopressin.
    Czaja M; Kruszyński M; Hinko A; Soloff MS
    Pol J Pharmacol; 1994; 46(5):429-37. PubMed ID: 7894530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of deamino-8-D-arginine vasopressin on urinary prostaglandins E2 and F2 alpha excretion.
    Walker L; Frölich JC
    Adv Prostaglandin Thromboxane Res; 1980; 7():1107-9. PubMed ID: 7369023
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of subcutaneous administration of arginine-8-vasopressin on the electroencephalogram of conscious rats are mediated by peripheral vasopressin V1 receptors.
    Ebenezer IS
    Methods Find Exp Clin Pharmacol; 1994 Jun; 16(5):315-21. PubMed ID: 7934310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrathecal vasopressin administration alters efferent renal nerve activity.
    Riphagen CL; Pittman QJ
    Proc West Pharmacol Soc; 1987; 30():175-7. PubMed ID: 3628272
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of microiontophoretically applied vasopressin and oxytocin on single neurones in the septum and dorsal hippocampus of the rat.
    Joëls M; Urban IJ
    Neurosci Lett; 1982 Nov; 33(1):79-84. PubMed ID: 7155451
    [No Abstract]   [Full Text] [Related]  

  • 29. A mechanism for vasopressin action in the hippocampus.
    Albeck D; Smock T
    Brain Res; 1988 Nov; 463(2):394-7. PubMed ID: 3196928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasopressin, oxytocin and memory: effects on consolidation and retrieval processes.
    Bohus B
    Acta Psychiatr Belg; 1980; 80(5):714-20. PubMed ID: 7234456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory and stimulatory action of vasopressin on the secretion of corticotrophin in rats : structure-activity study.
    van Dijk AM; Lodewijks HM; van Ree JM; van Wimersma Greidanus TB
    Life Sci; 1981 Sep; 29(11):1107-16. PubMed ID: 6270482
    [No Abstract]   [Full Text] [Related]  

  • 32. Vasopressin analogues and spatial short-term memory in rats.
    Buresová O; Skopková J
    Peptides; 1980; 1(3):261-3. PubMed ID: 7232229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of arginine vasopressin and its analogs on the synthesis of prostaglandin E2 by rat renal medullary interstitial cells in culture.
    Beck TR; Hassid A; Dunn MJ
    J Pharmacol Exp Ther; 1980 Oct; 215(1):15-9. PubMed ID: 7452479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The mechanisms of the effect of a vasopressin analog on the efficiency of glutamatergic transmission in the hippocampus].
    Kudriashov IE; Ivanova EM
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1995; 45(3):589-92. PubMed ID: 7645336
    [No Abstract]   [Full Text] [Related]  

  • 35. Vasopressin excites hippocampal neurones.
    Mühlethaler M; Dreifuss JJ; Gähwiler BH
    Nature; 1982 Apr; 296(5859):749-51. PubMed ID: 6122162
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of diabetes insipidus with synthetic vasopressin derivatives (effect of 1-deamino-8-D-arginine vasopressin and 1-deamino-valine-8-D-arginine vasopressin)].
    Czakó L; László F; Manning M
    Orv Hetil; 1980 Mar; 121(13):773-8. PubMed ID: 7383655
    [No Abstract]   [Full Text] [Related]  

  • 37. [Vasopressin and oxytocin].
    Yoshida H
    Horumon To Rinsho; 1973 Nov; 21(11):1113-6. PubMed ID: 4592116
    [No Abstract]   [Full Text] [Related]  

  • 38. Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus.
    Walker LA; Frölich JC
    J Pharmacol Exp Ther; 1981 Apr; 217(1):87-91. PubMed ID: 7205662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The potentiation of adjuvant arthritis in rats by vasopressin and its V2 agonist].
    Igonina NA; Evseev VA; Kulikova OS
    Patol Fiziol Eksp Ter; 1999; (3):30-1. PubMed ID: 10498993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolyl-leucyl-glycinamide (PLG) facilitates morphine dependence.
    van Ree JM; de Wied D
    Life Sci; 1976 Nov; 19(9):1331-9. PubMed ID: 1033445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.